Switch to:
GuruFocus articles
Headlines from internet
Nov-15-17$386.3 (+0.39%)
07:39AM5 Reasons Buy Dip Cramers Mad Money 11 14 17 Seekingalpha
Nov-14-17$384.8 (-2.24%)
08:07PMRegeneron Pharmaceuticals: Cramer's Top Takeaways theStreet
06:37PMBreaking Down This Downturn: Cramer's 'Mad Money' Recap theStreet
Nov-13-17$393.62 (-2.7%)
01:00PMInvestor Biases Aware Boost Returns Seekingalpha
08:04AMNovartis Looks Challenge Regenerons Turf Will Win War Seekingalpha
04:39AMNovartis vision drug shows positive trial results MarketWatch
12:56AMWeek Review November 10 2017 Seekingalpha
Nov-10-17$404.54 (-0.41%)
01:27PMPuma Biotechnology Faces Balance Sheet Anxiety Seekingalpha
Nov-09-17$406.21 (-2.16%)
11:31AMInovio (INO) Q3 Loss Wider Than Expected, Revenues Miss Zacks
08:16AMOphthotech (OPHT) Q3 Earnings & Sales Beat, Zimura in Focus Zacks
07:28AMBiotech Stock Roundup: Regeneron Delivers Strong Q3 Results, Cellectis Clinical Hold Lifted Zacks
06:58AMRegeneron Diversification Continues Work Done Seekingalpha
03:26AMDaily Pharma Scoop Portola Upside Novartis Reports Positive Cosentyx Data Keryx Tumbles Seekingalpha
Nov-08-17$415.17 (+2.67%)
03:35PMA Bright Spot in Blemished Biotech Barron's
11:16AMRegeneron (REGN) Beats on Q3 Earnings & Sales, Shares Up Zacks
09:16AMMorning Movers: Three Cuts and You’re Out? Barron's
07:50AMRegeneron's stock rallies after profit and sales rise above expectations MarketWatch
07:09AMRegeneron (REGN) Q3 Earnings Beat Estimates Zacks
06:46AMFutures point to a weak open on Wall Street, ahead of 21st Century Fox, Wendy’s, Square earnings cnbc
06:06AMTax Reform, Election Wins for Democrats and Snap - 5 Things You Must Know Before the Market Opens theStreet
05:59AMDow set to cool its heels after another record close MarketWatch
Nov-07-17$404.39 (-0.55%)
10:01AMHere's Why Regeneron Pharmaceuticals Inc. Slipped 10% in October Fool
Nov-06-17$406.63 (-0.44%)
02:19PMInovio (INO) Q3 Earnings: Is a Beat in Store for the Stock? Zacks
09:50AMNot Rewarding Surprises Like It Used To: Global Week Ahead Zacks
07:04PMFutures Up After Lukewarm Jobs Report Friday theStreet
12:10PMEarningsWatch: Disney, Nvidia, Snap headline a week of media and tech MarketWatch
09:44AMSurprise Arrest of Saudi Billionaire Alwaleed Bin Talal Overshadows Big Earnings theStreet
Nov-03-17$408.41 (+2.76%)
04:24PMWhat's in the Cards for Adverum (ADVM) This Earnings Season? Zacks
01:03PMRegeneron Gets Another Shot Barron's
09:21AMWill Regeneron Pharma (REGN) Disappoint in Q3 Earnings? Zacks
Nov-02-17$397.45 (+0.11%)
12:00PMThis Biotech Scientist Says Washington Needs to Remember the Basics Bloomberg
08:34AMSanofi (SNY) Q3 Earnings In Line, Sales Lag, Diabetes Weak Zacks
Nov-01-17$397 (-1.4%)
04:07PMBiotechs Behaving Badly Analysis Seekingalpha
Oct-31-17$402.62 (-0.96%)
06:46AMSouthwest Airlines Still Cheap Cramers Lightning Round 10 30 17 Seekingalpha
Oct-30-17$406.52 (-0.66%)
08:53PMSouthwest Airlines, QVC Group, Axalta Coating: 'Mad Money' Lightning Round theStreet
Oct-26-17$416.04 (-1.4%)
10:21AMAmgen (AMGN) Q3 Earnings Top, Sales Decline Y/Y, Stock Falls Zacks
09:53AMBiotech ETFs tumble, with Celgene's stock headlining weakness MarketWatch
Oct-25-17$421.93 (-1.07%)
11:42AMRoche Buying Dip Seekingalpha
Oct-24-17$426.51 (-1.44%)
03:21PMDaily Pharma Scoop Valeant Value Trap Agenus Upside Celgenes Potential Seekingalpha
08:17AMIs Regeneron Pharmaceuticals, Inc. Stock a Buy? Fool
Oct-23-17$432.76 (-0.05%)
07:35PMThe Hartford, Aetna Ink Tie-Up; All Eyes on Peanut Allergies -- ICYMI theStreet
03:05PMMight Best Time Pick Aerie Pharmaceuticals 2017 Seekingalpha
12:32PMDaily Pharma Scoop Adamis Upside Potential J And Js Simponi Label Expansion Sgens Adcetris Seekingalpha
Oct-20-17$432.98 (-1.81%)
03:57PMAnother Regeneron Bear Is Born Barron's
Oct-18-17$439.37 (-0.72%)
02:34PMBoardroom pay has risen nearly 20%, twice the gain of the average American worker cnbc
06:32AMBiotech Stock Roundup: Exelixis Soars on Priority Review, FDA Panel Supports Spark Drug Zacks
Oct-17-17$442.56 (-0.7%)
11:03PMValue System Amgen Looks Undervalued Seekingalpha
04:10PMMedicines Company May Best Investment 2017 Seekingalpha
09:48AMSanofi/Regeneron's Dupixent Succeeds in Phase II Study Zacks
Oct-16-17$445.68 (+0.61%)
11:18AMJohnson & Johnson earnings: All eyes on hurricane impact MarketWatch
07:20AMAimmune Teams With Regeneron on Finding Peanut Allergy Cure Bloomberg
Oct-13-17$442.96 (-0.94%)
05:11AMHow to invest in health-care stocks regardless of what happens in Washington, D.C. MarketWatch
Oct-11-17$452.97 (-1.77%)
01:33PMAnaptysbio Atopic Dermatitis Data Impresses Buy Secondary Seekingalpha
Oct-10-17$461.13 (-1.8%)
01:40PMA Short-Term Stock Pullback Is Coming - Here's How to Play Your Cards Right theStreet
Oct-09-17$469.56 (-0.08%)
09:48AMRegeneron Stock Shows Promise Despite High Valuation Multiple Seekingalpha
08:48AMOmega Healthcare Investors Healthy Enough Us Seekingalpha
Oct-06-17$469.95 (+1.41%)
12:37PMUpdates Pcsk9 Inhibitor Legal Pipeline Scene Seekingalpha
Oct-05-17$463.4 (+1.61%)
10:13AMWhy Amgen is Sliding Barron's
Oct-03-17$455.63 (-1.43%)
07:01AMDaily Pharma Scoop Pfizer Buy Ablynx Pick Successful Vblt Dvax Rigl Seekingalpha
Sep-19-17$431.38 (-0.75%)
05:17PMDaily Pharma Scoop Nabrivas Potential Allergans Ip Gimmick Supernuss Positive Data Seekingalpha
12:29PMBiotech Pharma Stocks Soak Bottom Seekingalpha
Sep-18-17$434.64 (+0.27%)
07:52AMRegeneron Diversification Efforts Soon Yield Results Seekingalpha
Sep-14-17$441.26 (+0.8%)
02:09PMSwoop Pick Regeneron Month Seekingalpha
08:55AMAmgen Needs Get Lucky Repatha Seekingalpha
Sep-12-17$444.48 (-0.14%)
11:48AMRegenerons Frustrating Month Analysis Commentary Seekingalpha
Sep-11-17$445.11 (-5.6%)
03:19PMOutlook Regenerons Potential Break Immune Checkpoint Inhibition Seekingalpha
08:00AM3 Things Biotech Learn Today September 9 2017 Seekingalpha
Sep-08-17$471.49 (-0.09%)
08:20AMIntellia Long Haul Seekingalpha
Aug-28-17$479.22 (+0.3%)
06:51AMMartin Shkreli: This Week In Investing (19) Seekingalpha
Aug-25-17$477.8 (-1.54%)
08:32AMDaily Insider Ratings Round Up 8/23/17: LE, AAT, XNCR Seekingalpha
Aug-21-17$469.74 (+0.38%)
01:23PMOphthotech: 3 Strikes And It's Out? Seekingalpha
Aug-15-17$472.57 (-0.42%)
07:00AM3 Things In Biotech You Should Learn Today: August 15, 2017 Seekingalpha
Aug-09-17$474.09 (+0.94%)
03:39PMEsperion's Triple Combo Hits A Home Run Seekingalpha
02:36PMDermira Grabs Big Pharma Castoff Seekingalpha
Aug-08-17$469.68 (-0.09%)
03:13PMDupixent Asthma Data Could Seal A Second Blockbuster Market Seekingalpha
12:53AMReassessing Regeneron Seekingalpha
Aug-07-17$470.1 (+0.29%)
08:19AMJohnson & Johnson Receives Massive 'No' From Panel: Hope Left? Seekingalpha
Aug-04-17$468.76 (+0.35%)
11:20AMRegeneron: High Growth, High Valuation Seekingalpha
Aug-03-17$467.11 (-2.04%)
02:13PMRegeneron: Wait, I Thought It Was Good News?!?! Barron's
Aug-02-17$476.82 (+1.02%)
09:04AMRegeneron: Time to Sell? Barron's
Jul-31-17$491.62 (-3.36%)
02:16PMAmgen Looks To Enhance Its Cholesterol Drug Seekingalpha
02:10PMClementia Pharmaceuticals Readies $100 Million IPO Seekingalpha
Jul-24-17$521.22 (+1.03%)
01:35AMThe Trump Rally Has Been Good: This Approach Is Better Seekingalpha
Jul-20-17$521.13 (+2.83%)
06:40AMCypress Semiconductor Will Go To $17 - Cramer's Lightning Round (7/19/17) Seekingalpha
Jul-19-17$506.79 (+1.84%)
02:09PMFDA's Flashing Green Light Boosts Novel Drug Approvals Seekingalpha
Jul-13-17$505.05 (+1.62%)
02:50PMCytRx: SCLC Study Still Breathing? Seekingalpha
Jul-10-17$499.91 (+0.69%)
01:10PMStrong Small Cap Performance Drives Second-Quarter Gains Seekingalpha
Jul-07-17$496.5 (+1.29%)
10:23AMBig Cap Biopharma Ends The Half Year On A High Note Seekingalpha
09:00AM3 Things In Biotech You Should Learn Today: July 2, 2017 Seekingalpha
Jun-30-17$491.14 (-3.68%)
11:46AMCan Regeneron Hit $540? Barron's
Jun-28-17$513.19 (+2.2%)
11:20AMComments On REVEAL, Merck's CTEP Inhibitor Study Seekingalpha
Jun-26-17$515.91 (-0.27%)
12:56PMBiotech Boom!: Overview And Company-By-Company Review Seekingalpha
Jun-23-17$517.33 (-1.75%)
04:11AM3 Things In Biotech You Should Learn Today: June 23, 2017 Seekingalpha
Jun-22-17$526.53 (+0.86%)
01:24PM#Regeneron: How High Can It Go? Barron's
11:33AMCantos Could Make Ilaris A Blockbuster Seekingalpha
10:00AM3 Things In Biotech You Should Learn Today: June 22, 2017 Seekingalpha
07:33AMMarket Is Divided Between Growth And Value - Cramer's Mad Money (6/21/17) Seekingalpha
Jun-21-17$522.02 (+5.39%)
09:02AMPut Regeneron On Your Investment Radar In 2017 Seekingalpha
Jun-20-17$495.33 (+5.02%)
03:38PMBiotech Is Well-Positioned To Outperform Seekingalpha
02:56PMIt's Time To Take Profits On Regeneron Seekingalpha
11:56AMThe Eyes Have It! Why #Regeneron Is Hitting A 52-Week High Barron's
11:16AMBrolucizumab Provides Some Comfort For Novartis Seekingalpha
Jun-16-17$459.91 (-2.04%)
03:14PMWhy Celgene is Bucking #Biotech Weakness Today Barron's
May-16-17$454.75 (+0.96%)
12:06PMRegeneron Will Still Be Heavily Reliant On Eylea Even If Sarilumab Becomes A Blockbuster Seekingalpha
May-10-17$431.57 (+1.03%)
09:03AMPieris Blooms With Astra Deal Seekingalpha
07:27AMAlibaba: The Enron Of The East? Seekingalpha
04:06PM5 Healthcare Innovators I'm Still Buying Seekingalpha
May-05-17$429 (-1.22%)
03:44PMCould Dupixent Be To Regeneron What Sovaldi Was To Gilead? Seekingalpha
09:16AMBiotech Forum Daily Digest: ACA Repeal Advances. Spotlight On Veracyte Seekingalpha
07:37AMMarket Is Seeing A Rotation - Cramer's Mad Money (5/4/17) Seekingalpha
May-04-17$434.31 (+6.7%)
06:54PMThe Hot Stock: Regeneron Pharma Soars 6.7% Barron's
May-03-17$407.03 (+1.24%)
02:42PMAdjusted EPS Helps Investors See Regeneron's Strong Earnings Power And Inexpensive Valuations Seekingalpha
May-02-17$402.04 (+1.48%)
07:55AM3 Things In Biotech You Should Learn Today: May 1, 2017 Seekingalpha
May-01-17$396.17 (+1.98%)
03:54PMAlnylam Teams Up With The Medicines Company To Upset PCSK9 Antibody Market Seekingalpha
11:45AMRegeneron: Solid New Drug Position Into Q1 Results Seekingalpha
07:02PMWhat's A Rating Worth? Not Much! Seekingalpha
Apr-27-17$366.62 (-1.28%)
02:08PMAmgen's Q1 Shows Challenges And Growth Opportunities Aplenty Seekingalpha
04:37AMWingstop Over B-Dubs - Cramer's Lightning Round (4/26/17) Seekingalpha
Apr-26-17$371.39 (-0.25%)
09:59AM3 Things In Biotech You Should Learn Today: April 26, 2017 Seekingalpha
Apr-24-17$371.93 (+0.49%)
07:22AMCelgene And Biogen Earnings Could Make Or Break The Biotech Sector Seekingalpha
Apr-21-17$370.12 (-1.67%)
08:33AMMedicare Drug Price Debate Puts Regeneron At Risk Seekingalpha
Apr-20-17$376.4 (+1.47%)
04:03PM3 Things In Biotech You Should Learn Today: April 20, 2017 Seekingalpha
Apr-13-17$370.37 (+1.1%)
09:44AMLarge Cap Biotech Review Pre-Earnings, Part 2 Seekingalpha
Apr-12-17$366.33 (-0.2%)
12:31PMThreats And Opportunities In Atopic Dermatitis: What's Next For Sanofi And Regeneron? Seekingalpha
09:00AM3 Things In Biotech You Should Learn Today: Volume 3 Seekingalpha
07:00PMDBV Shares Fall After Phase 3 Data on Peanut Allergy Treatment -- Biotech Movers theStreet
07:00PMDBV Shares Fall After Phase 3 Data on Peanut Allergy Treatment -- Biotech Movers theStreet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat